X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2023-02-15 | SNDX | Ordentlich Peter | Chief Scientific Officer | M - OptEx | $6.95 | +25,000 | 0 | -100% | +$173,791 | |||||
D | 2023-02-15 | SNDX | Ordentlich Peter | Chief Scientific Officer | S - Sale+OE | $25.84 | -25,000 | 0 | -100% | -$646,093 | |||||
D | 2023-02-01 | SNDX | Ordentlich Peter | Chief Scientific Officer | S - Sale+OE | $28.43 | -69 | 0 | -100% | -$1,962 | |||||
DM | 2022-12-01 | SNDX | Ordentlich Peter | Chief Scientific Officer | M - OptEx | $6.38 | +25,000 | 265 | -101% | +$159,387 | |||||
DM | 2022-12-01 | SNDX | Ordentlich Peter | Chief Scientific Officer | S - Sale+OE | $25.04 | -25,000 | 265 | -99% | -$626,025 | |||||
D | 2022-08-24 | SNDX | Ordentlich Peter | Chief Scientific Officer | M - OptEx | $6.32 | +25,000 | 265 | -101% | +$158,065 | |||||
D | 2022-08-24 | SNDX | Ordentlich Peter | Chief Scientific Officer | S - Sale+OE | $25.04 | -25,000 | 265 | -99% | -$625,893 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |